ArticlePDF Available

Amelioration of Experimental Acute Pancreatitis with Dachengqi Decoction via Regulation of Necrosis-Apoptosis Switch in the Pancreatic Acinar Cell

PLOS
PLOS ONE
Authors:

Abstract and Figures

Severity of acute pancreatitis contributes to the modality of cell death. Pervious studies have demonstrated that the herb medicine formula "Dachengqi Decoction" (DCQD) could ameliorate the severity of acute pancreatitis. However, the biological mechanisms governing its action of most remain unclear. The role of apoptosis/necrosis switch within acute pancreatitis has attracted much interest, because the induction of apoptosis within injured cells might suppress inflammation and ameliorate the disease. In this study, we used cerulein (10(-8) M)-stimulated AR42J cells as an in vitro model of acute pancreatitis and retrograde perfusion into the biliopancreatic duct of 3.5% sodium taurocholate as an in vivo rat model. After the treatment of DCQD, cell viability, levels of apoptosis and necrosis, reactive oxygen species positive cells, serum amylase, concentration of nitric oxide and inducible nitric oxide syntheses, pancreatic tissue pathological score and inflammatory cell infiltration were tested. Pretreatment with DCQD increased cell viability, induced apoptosis, decreased necrosis and reduced the severity of pancreatitis tissue. Moreover, treatment with DCQD reduced the generation of reactive oxygen species in AR42J cells but increased the concentration of nitric oxide of pancreatitis tissues. Therefore, the regulation of apoptosis/necrosis switch by DCQD might contribute to ameliorating the pancreatic inflammation and pathological damage. Further, the different effect on reactive oxygen species and nitric oxide may play an important role in DCQD-regulated apoptosis/necrosis switch in acute pancreatitis.
Content may be subject to copyright.
Amelioration of Experimental Acute Pancreatitis with
Dachengqi Decoction via Regulation of Necrosis-
Apoptosis Switch in the Pancreatic Acinar Cell
Jia Wang
1
, Guangyuan Chen
1
, Hanlin Gong
1
, Wei Huang
2
, Dan Long
3
, Wenfu Tang
1
*
1Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, PR China, 2Physiological Laboratory, University
of Liverpool, Liverpool, United Kingdom, 3Department of Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, PR
China
Abstract
Severity of acute pancreatitis contributes to the modality of cell death. Pervious studies have demonstrated that the herb
medicine formula ‘‘Dachengqi Decoction’’ (DCQD) could ameliorate the severity of acute pancreatitis. However, the
biological mechanisms governing its action of most remain unclear. The role of apoptosis/necrosis switch within acute
pancreatitis has attracted much interest, because the induction of apoptosis within injured cells might suppress
inflammation and ameliorate the disease. In this study, we used cerulein (10
28
M)-stimulated AR42J cells as an in vitro model
of acute pancreatitis and retrograde perfusion into the biliopancreatic duct of 3.5% sodium taurocholate as an in vivo rat
model. After the treatment of DCQD, cell viability, levels of apoptosis and necrosis, reactive oxygen species positive cells,
serum amylase, concentration of nitric oxide and inducible nitric oxide syntheses, pancreatic tissue pathological score and
inflammatory cell infiltration were tested. Pretreatment with DCQD increased cell viability, induced apoptosis, decreased
necrosis and reduced the severity of pancreatitis tissue. Moreover, treatment with DCQD reduced the generation of reactive
oxygen species in AR42J cells but increased the concentration of nitric oxide of pancreatitis tissues. Therefore, the
regulation of apoptosis/necrosis switch by DCQD might contribute to ameliorating the pancreatic inflammation and
pathological damage. Further, the different effect on reactive oxygen species and nitric oxide may play an important role in
DCQD-regulated apoptosis/necrosis switch in acute pancreatitis.
Citation: Wang J, Chen G, Gong H, Huang W, Long D, et al. (2012) Amelioration of Experimental Acute Pancreatitis with Dachengqi Decoction via Regulation of
Necrosis-Apoptosis Switch in the Pancreatic Acinar Cell. PLoS ONE 7(7): e40160. doi:10.1371/journal.pone.0040160
Editor: Juan Sastre, University of Valencia, Spain
Received January 6, 2012; Accepted June 1, 2012; Published July 2, 2012
Copyright: ß2012 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was supported by the grants of Natural Science Foundation of China (No: 30400576, 30973711 and 30672588). The funder had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wftang900@gmail.com
Introduction
Acute pancreatitis (AP) is an inflammatory condition that its
severe form involves systemic inflammatory response syndrome
(SIRS) and multiple organ dysfunction syndromes (MODS) [1,2].
The severity of AP depends largely upon the balance between two
forms of cell death-apoptosis and necrosis, the former presumed to
be predominantly protective with mild or no inflammatory
response, while necrosis, cell membrane integrity is lost, associated
with the release of the digestive enzymes and inflammatory
mediators, which can ultimately escalate local and systemic
damage [3,4]. A therapeutic agent that could induce apoptosis
of injured pancreatic acinar cells by regulating the apoptosis/
necrosis switch is likely to reduce necrosis and provide a new
effective treatment [3,5].
Free radicals are molecules produced continuously in cells by
several mechanisms and responsible for a wide variety of diseases
or conditions. It has been shown that reactive oxygen and nitrogen
species (ROS and RNS) contribute to the acinar cell damage
during the early phases of pancreatitis [6]. ROS can act as
a molecular trigger to activate oxidant-sensitive nuclear transcrip-
tion factor kappa B (NF-kB) and thus induces cytokine expression,
participating in various inflammatory processes. Moreover, an
important link between ROS generation and apoptosis has been
shown in both human and experimental pancreatitis. Numerous
studies have shown many anti-oxidant treatments significantly
reduce pancreatic injury and inflammation [7].
In AP, cytokines and other mediators derived from the inflamed
pancreas activate the production of the inducible nitric oxide
synthase (iNOS). An enhanced formation of nitric oxide (NO) due
to the induction of iNOS may be an important factor in the
systemic and local haemodynamic disturbances and regulation of
pancreatic exocrine secretion associated with AP. Excess of NO
cause hypotension and decrease blood perfusion of various organs,
including the pancreas and lung, correlating with apoptotic
changes [8]. Therefore, treatments that could regulate free
radicals ROS or RNS may directly contribute to the modality of
acinar cell death and the degree of inflammation.
Dachengqi Decoction (DCQD) composed of Radix et Rhizoma
Rhei (Dahuang), Cortex Magnoliae Officinalis (Houpu), Fructus Aurantii
Immaturus (Zhishi) and Natrii Sulphas (Mangxiao) is traditionally
used as the representative prescription purgative for the treatment
of constipation and for clearing internal heat in the stomach and
intestine [9]. In China, DCQD has been used to treat AP for over
30 years [10]. Recent studies have shown that DCQD can
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40160
promote gastrointestinal motility, inhibit cytokine activity and
immune inflammatory response in AP [11–13]. However, most of
its biological activities have been studied individually on its
ingredients. Studies designed to test the molecular mechanisms of
the compound herb formula DCQD in the modality of pancreatic
acinar cell death have not been elucidated to date.
Thus, in our present work, we studied the effect of DCQD in
regulating the inflammatory response via selective induction of
pancreatic acinar cell apoptosis and explored the regulation
mechanism of apoptosis/necrosis switch through its opposite effect
in regulating ROS and NO in vitro and in vivo.
Materials and Methods
1. Materials
1.1. Drugs and reagents. The spray-dried Radix et Rhizoma
Rhei,Cortex Magnoliae Officinalis,Fructus Aurantii Immaturus and Natrii
Sulphas powder were purchased from Chengdu Green Herbal
Pharmaceutical Co. Ltd (Chengdu, China). The spray-dried
powder was mixed of an equal amount and reconstituted with
sterile distilled water at concentrations for the crude drug of 2 g/
mL DCQD in vivo study [14]. In vitro study, the mixed powder was
reconstituted with PBS to prepare a 50 mg/mL stock solution in
dimethylsulfoxide (DMSO) and kept in 220uC. Before being
added to cells, the DCQD stock solution was diluted with PBS to
prepare the working solutions. The final DMSO concentrations
were all less than 0.1% when DCQD was added to cells. The dose
of DCQD was calculated and diluted according to its contents
quantitatively analyzed by HPLC system. Fetal bovine serum
(FBS) was obtained from HyClone (Logan, UT). DMSO,
Cerulein, F12K medium and DCFH-DA were obtained from
Sigma (St. Louis, MO, USA).
1.2. Rats. Sprague-Dawley rats (243618 g) were purchased
from the Experimental Animal Center of West China Center of
Medical Sciences of Sichuan University. All animal studies were
performed according to the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of the Sichuan University.
2. Methods
2.1. Cell culture. Rat pancreatic acinar AR42J cells (ATCC,
Rockville, MD, USA) were cultured in F12K medium containing
20% FBS and 100 U/mL penicillin, 100 mg/mL streptomycin in
standard condition (37uC and 5%CO
2
). All experiments were
carried out 24 h after cells were seeded. To investigate the
protective effects of DCQD against AP, AR42J cells were treated
with or without DCQD prior for 30 min, then further co-
incubated with cerulein (10
28
M) for another 24 h.
2.2. Cell viability assay. Cell survival was assessed by WST
viability assay kit containing WST-8(2-(2-methoxy-4-nitrophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monoso-
dium salt) according to the manufacturer’s protocol (Roche, Basel,
Switzerland). AR42J cells were plated in 96-well plates at 2610
4
cells/well. After 24 h incubation, cells were pretreated with or
without DCQD at different concentrations (0–0.004 g/mL) and
then were further co-incubated with cerulein for 24 h, WST-8
solution (0.5 mg/mL) was added to each well and incubated at 5%
CO
2
37uC for 2 h. The cell viability was determined by the
differences absorbance at wavelengths of 450 nm and 630 nm.
The relative cell viability rate was calculated according to the
following formula: Cell viability rate (%) = 100%6mean absor-
bance of cells in sample groups/mean absorbance for cells in
control group.
2.3. LDH assay. Necrotic cell death was assessed by the
release of lactate dehydrogenase (LDH) from the cytosol of the
damaged cells into the supernatant [15], using the LDH
cytotoxicity detection kit (Nanjing Jiancheng Bioengineering
Institute, Nanjing, China) for various time point 0–24 h according
to the manufacturer’s instructions. Values for LDH release are
presented as the percentage of total cellular LDH from the
following equation [16]: LDH release (%) = total extracellular
LDH activity at the time point6100/total LDH activity.
2.4. Apoptosis assay. Cells were stained with Annexin V-
FITC Apoptosis detection kit (Nanjing Kaiji, Nanjing, China)
following the manufacturer’s instructions to detect early apoptotic
cells (Annexin V+PI2events) and necrotic or late apoptotic cells
(Annexin V+PI+) by flow cytometry. Briefly, AR42J cells were
treated or not with DCQD prior for 30 min and then stimulated
with cerulein (10
28
M) for 24 h. Then cells were collected and
resuspended in the culture medium at a density of 1610
6
cells/
mL, stained with 5 mL of Annexin V-FITC and 5 mL propidium
iodide (PI) in 300 mL binding buffer (10 mM HEPES, pH 7.4,
140 mM NaOH, and 2.5 mM CaCl
2
) according to the manu-
facturer’s instructions for 15 min at room temperature in the dark.
Quantification of apoptotic cells was analysis by flow cytometry
(FACScan, Becton Dickinson, USA).
2.5. Measurement of ROS generation. The generation of
ROS in cells was determined using a FACScan flow cytometry
following the manufacturer’s instructions. Briefly, AR42J cells
were pretreated with DCQD 30 min before stimulated with
cerulein for 24 h. Cells were collected and incubated with 10 mM/
L DCFH-DA 30 min in the dark and then washed twice with PBS.
Intracellular low-molecular-weight peroxides oxidize DCFH-DA
to the highly fluorescent compound dichlorofluorescein (DCF).
Then the cells were harvested and the pellets were suspended in
300 ml PBS at an excitation wavelength of 488 nm and an
emission wavelength of 525 nm.
2.6. Animal models and treatment with DCQD. Sprague-
Dawley rats were divided randomly into sham-operated group, AP
group and DCQD- treated group (n = 6). While the rats were
under ether anesthesia and laparotomy, pancreatitis was induced
by retrograde perfusion into the biliopancreatic duct of 3.5%
sodium taurocholate (Sigma, St. Louis, MO, USA) (1 mL/kg body
weight) at a rate of 0.2 mL/min with a microinfusion pump [17].
The entire procedure from induction of anesthesia to closure of the
incisions requires ,30 min for each animal. The same procedure
was applied to sham-operated group but receiving an intraductal
perfusion of saline (NaCl 0.9%) instead of sodium taurocholate. In
DCQD- treated group, the rats recovered from anesthesia and
were administered intragastrically DCQD 20 g/kg body weight
(equivalent to 2 g/mL crude herbs) 2 h after operation. In the
sham-operated group and AP group, rats were given equal volume
of saline. After 48 h, blood were obtained from the vena caudalis
and centrifuged to obtain serum for amylase examination. The
animals were sacrificed by exsanguination while under ether
anesthesia and the pancreatic tissues were rapidly collected for
pathological and apoptotic examinations. Tissue homogenate was
collected for NO and iNOS concentration measurement.
2.7. Amylase and NO and iNOS Assay. Serum was
collected from the rats for amylase activity (U/L) measurement
by an enzymatic assay kit from Sigma (St. Louis, MO, USA)
according to manufacturer’s instructions. Tissue homogenate was
collected for NO and iNOS concentration measurement, using
nitric oxide and inducible nitric oxide synthetase assay kits (Nanjin
Jiancheng Biological engineering Company, Nanjin, China)
according to manufacturer’s instructions.
Dachengqi Decoction Regulates Cell Death Pathways
PLoS ONE | www.plosone.org 2 July 2012 | Volume 7 | Issue 7 | e40160
2.8. TUNEL assay. The apoptotic cells in tissue samples
were detected using an In Situ Cell Death Detection kit (Roche,
Switzerland) according to the manufacturer’s instructions. Briefly,
paraffin embedded specimens were cut into 4–5 mm thickness
sections. After deparaffinization and washed in PBS, The sections
were treated with proteinase K, then incubated with TUNEL
reaction mixture at 37uC for 1 h. Slides were washed with PBS
and then treated with HRP and DAB terminated until the color
was developed. Apoptotic index was determined by counting the
number of TUNEL-positive cells. Eight slides per block were
evaluated. For each slide, 8 fields were randomly chosen, and
`100
cells per field were counted and calculated the apoptosis index.
2.9. Histopathologic analysis of pancreas. At the end of
experiment, pancreatic tissues were promptly collected, fixed in
10% neutral formalin and embedded in paraffin. The paraffin-
embedded tissue blocks were cut into 5 mm thick sections and
stained with hematoxylin and eosin. Specimens were graded by
two independent pathologists blinded to the experimental setup
using a scoring system for the extent and severity of pancreatitis
(0–4, normal to severe, respectively), the degree of interstitial
edema, hemorrhage, hyperemia, necrosis, leukocyte infiltration of
the pancreatic tissue as previously described [18,19].
2.10. Leukocyte infiltration assay. For evaluation of the
infiltration number of leukocyte during pancreatitis we randomly
chose 8 to 10 consecutive high-power fields for each rat (n = 6) on
a scale of 0–4 by two researchers in a blinded manner as
previously described [18,19].
3. Statistical analysis
Statistical analysis was carried out using the PEMS3.1 statistical
program. All data represent at least three independent experi-
ments and are expressed as the mean 6standard errors of mean
(S.E.M.). One-way repeated-measures ANOVA (followed by
multiple pair-wise comparisons using Student-Neuman-Keuls
procedure) were used for the analysis of differences between the
experimental and control groups. Values of P,0.05 were regarded
as statistically significant.
Results
1. DCQD enhanced cerulein-induced AR42J cell viability
In order to examine the effect of DCQD on cell viability,
pancreatic acinar AR42J cells were treated with increasing
concentrations of DCQD (0.00025 g/mL, 0.0005 g/mL,
0.001 g/mL, 0.002 g/mL and 0.004 g/mL) for 0–24 hours based
on the components’ concentrations of DCQD in blood of our
previous study [20,21]. As shown in Figure 1A, there were few
dead cells present in the control group, and the cell viability
significantly decreased after cerulein was added. Treatment of
AR42J cells with DCQD for 24 hours caused a concentration-
dependent protective effect, and the maximum effect was obtained
at the dose of 0.004 g/mL. The viability of cells pretreated with
0.004 g/mL DCQD for 24 h increased significantly compared to
the cerulein stimulated group. One characteristic of pancreatic
acinar cell stimulated with supramaximal doses of cerulein is the
induction of necrosis [16]. The process of necrosis damages the
plasma membranes, and release LDH into the extracellular
medium. To evaluate necrosis in the present study, we measured
the release of LDH from the damaged AR42J cells following 24 h
treatment with cerulein. The release of LDH in the control group
was at relatively lower levels, and the levels of LDH significantly
increased after the addition of cerulein and different concentra-
tions of DCQD. The level of necrotic cells was decreased after the
pretreatment of DCQD with increased concentration. In our
study, supramaximal cerulein treatment significantly increased
LDH release from pancreatic acinar cells. However, pretreatment
with 0.004 g/mL DCQD significantly diminished LDH release
compared to the cerulein-stimulated cell AP model group at 24 h
(Figure 1B).
2. DCQD induced pancreatitis AR42J cells apoptosis
To determine the effects of inducing apoptosis by DCQD on
AR42J cells, we further analyze apoptosis using Annexin V/PI
Figure 1. Effects of DCQD on the reduction of cerulein-induced
necrosis of AR42J cells. The cells were pre-treated with increasing
concentrations of DCQD (0.00025 g/mL, 0.0005 g/mL, 0.001 g/mL,
0.002 g/mL and 0.004 g/mL) for 30 min and then co-incubated with
or without 10
28
M cerulein for another 0–24 h. (A) Cell viability rate was
examined using WST-8 assay. (B) Necrotic cell death rate was assessed
by the release rate of LDH. The results are mean 6SE (n = 5) for three
independent experiments. *P,0.05 versus control group; +P,0.05
versus DCQD 0.004 g/mL group;ˆP,0.05 versus cerulein group.
doi:10.1371/journal.pone.0040160.g001
Dachengqi Decoction Regulates Cell Death Pathways
PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e40160
staining. The Annexin V2/PI2population was regarded as
normal healthy cells, while Annexin V+/PI2cells were taken as
a measure of early apoptosis and Annexin V+/PI+as necrosis/late
apoptosis. Our results showed that there was a very low level of cell
death in the control group, 24 h treatment with cerulein
significantly increased cell death (Figure 2A). In the AP group,
there were fewer apoptotic cells but more necrotic cells (Figure 2B).
After pretreated with DCQD, the number of apoptotic cells
increased and the number of necrotic cells decreased significantly
comparing with AP group cells at 24 h (Figure 2C).
3. DCQD reduced ROS in cerulein-induced AR42J cells
Acinar cellular damage induced by supramaximal cerulein
could originate from premature intracellular enzyme activation,
but also from injurious levels of ROS. We explored whether
DCQD could diminish the supramaximal cerulein-induced
necrosis by interfering with ROS production. The ROS positive
cells pretreated with or without DCQD before stimulated with
cerulein for 24 h were analyzed (Figure 2D). A very low level of
ROS positive cells were detected in the control group, but in AP
group ROS positive cells significantly increased. DCQD pre-
treated pancreatic acinar cells before cerulein stimulating signif-
icantly decreased ROS positive cells remarkably (Figure 2E).
4. DCQD reduced the release of serum amylase in the
rats’ model of AP
Sodium taurocholate stimulation caused a statistically significant
increase of serum amylase at 48 h in the AP group compared with
the sham-operated group in vivo. In DCQD-treated group, the
serum amylase values were significantly lower than that in the AP
group (Figure 3A).
5. DCQD induced apoptosis of pancreatitis acinar cells
determined by TUNEL staining
TUNEL-stained slides revealed that pancreas tissue from sham-
operated rats exhibited very low levels of apoptosis. In contrast,
a significant number of TUNEL-positive cells were detected in
pancreas tissue within the AP group and DCQD- treated group at
48 h. Treatment with DCQD significantly increase the percentage
of TUNEL-positive cells compared with the AP group (Figure 3B).
This result indicates that DCQD may preferentially induce
apoptosis within injured cells, which is consistent with our in vitro
study.
6. DCQD alleviated the severity of experimental AP
In the sham-operated group, the pancreas was few edematous,
with the infiltration of a few inflammatory cells but without
obvious hemorrhage, necrosis of acinar cells or the adjacent fat
tissues. However, the AP group showed the features of a severe
form of AP characterized by expansion of interlobular and
interlobular spaces caused by moderate to severe interstitial
edema, extensive infiltration with inflammatory cells, obvious
pancreatic acinar cells vacuolization, necrosis and hemorrhage
(Figure 3C). The rats treated with DCQD showed a significant
reduction of inflammatory cells infiltration, hemorrhage, necrosis
and interstitial edema compared to the AP group. The standard
pathological scores in both AP and DCQD-treated groups
significantly exceeded the sham-operation group at 48 h. The
scores of DCQD-treated group were significantly lower than those
of the AP group at 48 hours (Figure 3D).
Figure 2. DCQD regulated cerulein-induced AR42J necrosis-apoptosis switch through ROS. The cells were pre-treated with 0.004 g/mL
DCQD for 30 min and then co-incubated with or without 1028 M cerulein for another 24 h. (A) Flow cytometry analysis of the apoptotic and necrotic
cells among the AR42J cells. Four different regions can be found in each panel in the figure for flow cytometry detection: Viable cells (Annexin V2/
PI2) are located in the lower left, early apoptotic cells (Annexin V+/PI2) in the lower right, late apoptotic and necrotic cells (Annexin V+/PI+) in the
upper right and primary necrotic cells (Annexin V2/PI+) in the upper left quadrants, respectively. (B) The percentages of apoptotic cells and (C)
necrotic cells were compared. (D) Generation of ROS in AR42J cells were detected by DCF using flow cytometry (E) and ROS positive cells were
compared. The results are mean 6SE for three independent experiments.
#
P,0.05 and
##
P,0.01 versus control cells;
*
P,0.05 and
**
P,0.01 versus
AP group.
doi:10.1371/journal.pone.0040160.g002
Dachengqi Decoction Regulates Cell Death Pathways
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e40160
7. DCQD reduced the leukocyte infiltration of pancreatitis
tissues
In AP group, there was a significant increase of leukocyte
infiltration of pancreas tissue at 48 h after sodium taurocholate
stimulation compared with the sham-operated group. In DCQD-
treated group, leukocyte infiltration was significantly lower than
that in the AP group (Figure 3E).
8. DCQD enhanced the acute pancreatitis-associated
tissue concentration of NO and iNOS
There were significant differences in the concentration of NO
and iNOS among the groups. The results showed that the
concentration of NO and iNOS in the AP group were significantly
lower than that in the sham-operated group, whereas the
concentration of NO and iNOS in the DCQD-treated group
were significantly higher than that in the sham-operated group at
48 h (Figure 4). These results suggest that treatment with DCQD
Figure 3. DCQD alleviated acute pancreatitis-associated tissue damage. Rats (n = 6 per group) were given DCQD (20 g/kg body weight) 2 h
after operation. After 48 h, the blood was obtained for amylase examination. The pancreatic tissues were collected for examination of pathological
and apoptotic examinations (A) Serum amylase activity assay. (B) TUNEL-positive cells percentage in the pancreatic tissue. (C) Pathological changes of
pancreas in different groups observed by HE staining (Light microscopy, 6400). Sham-operated group rats showed slightly edematous. Compared
with sham-operated rats, AP group rats showed a severe degree of pancreatic damage with edema, hemorrhage, necrosis, pancreatic acinar cell
vacuolization and infiltration of inflammatory cells. In DCQD-treated group, rats showed a reduction of edema, hemorrhage, necrosis, and
inflammatory cells infiltration. (D) Pathological scores of pancreatic injury (E) and leukocyte infiltration counted in 8 to 10 consecutive high-power
fields per slide of Sham-operated group, AP group and DCQD-treated group. The results are mean 6SE for three independent experiments.
#
P,0.05
and
##
P,0.01 versus sham-operated group;
*
P,0.05 and
**
P,0.01 versus AP group.
doi:10.1371/journal.pone.0040160.g003
Dachengqi Decoction Regulates Cell Death Pathways
PLoS ONE | www.plosone.org 5 July 2012 | Volume 7 | Issue 7 | e40160
could increase the production of NO in pancreatic tissues, which is
a major factor correlated with the appearance of apoptosis.
Discussion
AP is a multifactorial disease associated with the excessive
inflammatory response, which can ultimately lead to devastating
consequences. The form of cell death determines the severity of
AP. Recent studies prove the apoptosis could be a beneficial
reaction to AP, because apoptotic cells maintain membrane
integrity, therefore, unlike necrotic cells, the leakage of in-
tracellular components containing proinflammatory and immu-
nogenic materials could be prevented actively to avoid in-
flammatory response [3,22]. Crucially the two kinds of cell
death, necrosis and apoptosis, may be interchangeable under
certain conditions [23]. Therefore, if the therapeutic agent could
regulate the apoptosis/necrosis switch, it might inhibit the
inflammatory response, protecting against progression toward AP.
In some in vivo studies, the modified formula of DCQD and its
components exhibited potencies in inducing apoptosis of pancre-
atitis acinar cell [24,25]. This study shows that DCQD promotes
acinar cell apoptosis both in vitro and in vivo models of AP with
a reduction in necrosis, suggesting a switch from deleterious
necrotic cell death to a milder apoptotic form. Additionally,
pancreatic tissue necrosis, hemorrhage and inflammatory cell
infiltration were significantly alleviated in DCQD-treated group in
vivo. The concentration of LDH in the supernatant of the culture
solution can indirectly reflect cell membrane damage resulting in
necrosis [26]. It was seen that both the number of necrotic cell and
the level of LDH were lower in DCQD-treated group than in the
AP group in vitro. The plasma concentration of amylase is another
parameter for the severity of AP. In this study, its levels were
significantly lower in DCQD-treated group than in the AP group
in vivo. The treatment mechanism of DCQD may occur via
inducing apoptosis of injured acinar cells, decreasing necrosis,
which help to avoid the release of digestive enzyme and various
inflammatory mediators, significantly attenuating the progression
of pancreatic injury.
Oxidative stress is regarded as an important determinant of the
severity of acute pancreatitis [27]. Large amounts of ROS can
directly activate the oxidant-sensitive transcription factor of NF-kB
and generate an inflammatory response, which attracts more
oxidative stress-generating neutrophils to worsen local tissue
destruction and to cause distant organ injury [28,29]. Moreover,
it has been demonstrated that the level of ROS involved in
apoptosis/necrosis switch [30,31]. In our study, there was a lower
level of ROS and necrosis but a higher level apoptosis in DCQD-
treated group than in AP group in vitro, indicating that DCQD
have the antioxidant effect to reduce the production of ROS and
might switch acinar cells death from necrosis to apoptosis,
alleviating subsequent inflammatory response.
The role of NO in the pathogenesis of AP remains controversial.
Some studies showed that the proinflammatory cytokines activate
the production of the iNOS, resulting in overproduction of NO,
which could promote pancreatic injury [32,33]. Whereas others
reported that NO acts as a biological scavenger and inactivates
ROS, which protects pancreatic acinar cells [34] and has also
beneficial effects by inhibition of neutrophil accumulation and
improvement of microcirculation [35,36]. Our data showed that
after treated with DCQD, the production of NO in pancreatic
tissues was increased, accompanying the increase of apoptosis with
the decrease of inflammatory cells infiltration and pathological
scores in pancreatic tissues. This indicated that the increase of NO
and iNOS was not the reason of pancreatic tissue damage, but
a protective factor might be involved in inducing apoptosis and
reduce pancreatic tissue pathological severity.
ROS and nitrogen oxide species play important and different
roles in various physiological and pathological states. In our study,
DCQD exerting an opposite regulation on NO and ROS may
come from its scavenging effects which remain to be understood.
These findings provided evidence that treated with DCQD reduce
the generation of ROS and increase the NO pancreatitis acinar
cells, therefore regulate apoptosis/necrosis switch, induce apopto-
sis of injured acinar cells and inhibit the subsequent amplifying
inflammatory response, which in turn protects against AP.
In the present study, we introduce the ideas and methods of
translating research into traditional Chinese medicine, and this is
the first time to research the way of compound Chinese herb
formula DCQD regulating apoptosis/necrosis switch on AP in vitro
and in vivo. Here we conclude that DCQD could inhibit the local
and systematic inflammatory response and alleviate the pancreatic
damage via regulating the pancreatic cell necrosis/apoptosis
switch. Future study should be directed at signaling pathways of
ROS and NO in regulating injured pancreatitis acinar cell
apoptosis by the treatment of DCQD.
Author Contributions
Conceived and designed the experiments: WFT JW. Performed the
experiments: JW GYC HLG WH. Analyzed the data: DL. Contributed
reagents/materials/analysis tools: GYC HLG WH. Wrote the paper: JW.
Figure 4. DCQD enhanced the acute pancreatitis-associated
tissue concentration of NO and iNOS. Tissue homogenates were
collected for NO and iNOS concentration measurement after 48 h
treatment. (A) NO concentration (B) and iNOS concentration of sham-
operated group, AP group and DCQD-treated group. The results are
mean 6SE (n = 6 per group) for three independent experiments.
#
P,0.01 versus sham-operated group;
*
P,0.01 versus sham-operated
group and AP group.
doi:10.1371/journal.pone.0040160.g004
Dachengqi Decoction Regulates Cell Death Pathways
PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e40160
References
1. Bhatia M (2009) Acute pancreatitis as a model of SIRS. Front Biosci 1: 2042–
2050.
2. Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, et al. (2006)
Association between early systemic inflammatory response, severity of multi-
organ dysfunction and death in acute pancreatitis. Br J Surg 93: 738–744.
3. Kaiser AM, Saluja AK, Sengupta A, Saluja M, Steer ML (1995) Relationship
between severity, necrosis, and apoptosis in five models of experiment al acute
pancreatitis. Am J Physiol Cell Physiol 269: C1295–C1304.
4. Bhatia M (2004) Apoptosis versus necrosis in acute pancreatitis. Am J Physiol
Gastrointest Liver Physiol 286: G189–G196.
5. Mareninova OA, Sung KF, Hong P, Lugea A, Pandol SJ, et al. (2006) Cell death
in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 281:
3370–3381.
6. Chvanov M, Petersen OH, Tepikin A (2005) Free radicals and the pancreatic
acinar cells: role in physiology and pathology. Philos Trans R Soc Lond B Biol
Sci 360: 2273–2284.
7. Liu B, Yang P, Ye Y, Zhou Y, Li L, et al. (2011) Role of ROS in the protective
effect of silibinin on sodium nitroprusside-induced apoptosis in rat pheochro-
mocytoma PC12 cells. Free Radic Res 45: 835–847.
8. Leindler L, Morschl E, La´szlo´F,Ma´ndi Y, Taka´ cs T, et al. (2004) Importance of
cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing
pancreatitis in rats. Pancreas 29: 157–161.
9. Katakai M, Akamaru T, Tani T (2002). An analysis of the frequency of
formulations and crude drugs described in Shan-Han-Lun. Yakushigaku Zassh
37: 28–35.
10. Xia Q, Jiang JM (2001) The research on the mechanism of ‘TongLi GongXia’
method to treat acute pancreatitis. Chin J Bases Clin General Surg 8: 131–132.
11. Lu GH, Wang CH, Wang LX, Lu YP, Gao WY, et al. (2008) Dynamic Changes
of Pro-and Anti-Inflammatory Cytokine of Sever Acute Pancreatitis Rats and
Regulative Effection of Da-Cheng-Qi Decoction. Chinese Archives of
Traditional Chinese Medicine 27: 260–262.
12. Wan MH, Li J, Gong HL, Xue P, Zhu L, et al. (2011) Clinical observation on
the effect of dexamethasone and Chinese herbal decoction for purgation in
severe acute pancreatitis patients. Chin J Integr Med 17: 141–145.
13. Xia Q, Huang ZW, Jiang JM, Cheng GY, Yang XL, et al. (2006) Yi-Huo-Qing-
Xia method as the main therapy in integrated traditional Chinese and western
medicine on severe acute pancreatitis: a report of 1161 cases. Chin J TCM WM
Crit Care 13: 131–134.
14. Tang WF, Huang X, Yu Q, Qin F, Wan MH, et al. (2007) Determination and
pharmacokinetic comparison of rhein in rats after oral dosed with Da-Cheng-Qi
decoction and Xiao-Cheng-Qi decoction. Biomed Chromatogr 21: 1186–1190.
15. Abdel-Latif L, Murray BK, Renberg RL, O’Neill KL, Porter H, et al. (2006)
Cell death in bovine parvovirus-infected embryonic bovine tracheal cells is
mediated by necrosis rather than apoptosis. J Gen Virol 39: 2539–2548.
16. Yu JH, Kim KH, Kim DG, Kim H (2007) Diphenyleneiodonium suppresses
apoptosis in cerulein-stimulated pancreatic acinar cells. Int J Biochem Cell Biol
39: 2063–2075.
17. Hietaranta AJ, Peuravuori HJ, Nevalainen TJ (1995) Phospholipase A2 in
sodium taurocholate-induced experimental hemorrhagic pancreatitis in the rat.
J Surg Res 59: 271–278.
18. Weber H, Wagner AC, Jonas L, Merkord J, Ho¨ fken T, et al. (2000) Heat shock
response is associated with protection against acute interstitial pancreatitis in
rats. Dig Dis Sci 45: 2252–2264.
19. Rakonczay Z Jr, Taka´ cs T, Iva´nyi B, Ma´ndi Y, Pa´ pai G, et al. (2002) The effects
of hypo-and hyperthermic pretreatment on sodium taurocholate-induced acute
pancreatitis in rats. Pancreas 24: 83–89.
20. Gong HL, Tang WF, Yu Q, Xiang J, Xia Q, et al. (2009) Effect of severe acute
pancreatitis on pharmacokinetics of Da-Cheng-Qi Decoction components.
World J Gastroenterol 15: 5992–5999.
21. Tang WF, Wan MH, Zhu ZY, Chen GY, Huang X (2008) Simultaneous
determination of eight major bioactive compounds in Dachengqi Tang (DT) by
high-performance liquid chromatography. Chin Med 29: 5.
22. Bhatia M (2004) Apoptosis of pancreatic acinar cells in acute pancreatitis: is it
good or bad? J Cell Mol Med 8: 402–409.
23. Criddle DN, Gerasimenko JV, Baumgartner HK, Jaffar M, Voronina S, et al.
(2007) Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell
Death Differ 14: 1285–1294.
24. Shang D, Guan FL, Chen HL, Yang PM, Xin Y, et al. (2002) Effec t of
Yinchenchengqi Decoction on Severe Acute Pancreatitis for Apoptosis of Acinar
Cells and Expression of Bax. Chinese Journal of Surgery of Integra ted
Traditional and Western Medicine 8: 70–73.
25. Chang YC, Lai TY, Yu CS, Chen HY, Yang JS, et al. (2011) Emodi n Induces
Apoptotic Death in Murine Myelomonocytic Leukemia WEHI-3 Cells In Vitro
and Enhances Phagocytosis in Leukemia Mice In Vivo. Evid Based Complement
Alternat Med May 10 [Epub ahead of print].
26. Hu G, Shen J, Cheng L, Guo C, Xu X, et al. (2011) Reg4 protects against acinar
cell necrosis in experimental pancreatitis. Gut 60: 820–828.
27. Tsai K, Wang S, Chen T, Kong C, Chang F, et al. (1998) Oxidative stress: an
important phenomenon with pathogenetic significance in the progression of
acute pancreatitis. Gut 42: 850–855.
28. Pereda J, Sabater L, Aparisi L, Escobar J, Sandoval J, et al. (2006) Interaction
between cytokines and oxidative stress in acute pancreatitis. Curr Med Chem 13:
2775–2787.
29. Kim H, Seo JY, Roh KH, Lim JW, Kim KH (2000) Suppression of NF-kappaB
activation and cytokine production by N-acetylcysteine in pancreatic acinar
cells. Free Radic Biol Med 29: 674–683.
30. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, et al. (2009) RIP3, an energy
metabolism regulator that switches TNF-induced cell death from apoptosis to
necrosis. Science 325: 332–336.
31. Booth DM, Murphy JA, Mukherjee R, Awais M, Neoptolemos JP, et al. (2011)
Reactive Oxygen Species Induced by Bile Acid Induce Apoptosis and Protect
Against Necrosis in Pancreatic Acinar Cells. Gastroenterology 140: 2116–2125.
32. Rahman SH, Ammori BJ, Larvin M, McMahon MJ (2003) Increased nitric
oxide excretion in patients with severe acute pancreatitis: evidence of an
endotoxin mediated inflammatory response? Gut 52: 270–274.
33. Um SH, Kwon YD, Kim CD, Lee HS, Jeen YT, et al. (2003) The role of nitric
oxide in experimental cerulein induced pancreatitis. J Korean Med Sci 18: 520–
526.
34.RubanyiGM,HoEH,CantorEH,LummaWC,BotelhoLH(1991)
Cryoprotective function of nitric oxide: inactivation of superoxide radicals
produced by human leukocytes. Biochem Biophys Res Comm 181: 1392–1397.
35. Cevikel MH, Ozgu¨ n H, Boylu S, Demirkiran AE, Sakarya S, et al. (2003) Nitric
oxide regulates bacterial translocation in experimental acute edematous
pancreatitis. Pancreatology 3: 329–335.
36. Dobosz M, Hac S, Mionskowska L, Dymecki D, Dobrowolski S, et al. (2005)
Organ microcirculatory disturbances in experimental acute pancreatitis. A role
of nitric oxide. Physiol Res 54: 363–368.
Dachengqi Decoction Regulates Cell Death Pathways
PLoS ONE | www.plosone.org 7 July 2012 | Volume 7 | Issue 7 | e40160
... Its main ingredients include Houpu, Da Huang, Mangxiao, and Zhi Shi (7). DCQD appears positively associated with the improvement of pancreatic microcirculation in SAP (8,9). However, it is a pity that the concrete mechanism that DCQD regulates HMGB1 activation and microcirculation is not clear to date. ...
... The DCQ granules collected were dissolved in saline to obtain DCQD (2 g/mL). According to the previous article, the concrete, specific compatibility, steps, extraction, and use (9). ...
... The insulin injection needle was stretched into the biliopancreatic duct by the nipple, and sodium taurocholate (1 mg/ kg) got into the biliopancreatic duct by injection. After 2h of injecting sodium taurocholate, the animal in the EX527, DCQD, and r-HMGB1 group were treated with DCQD using an oral gavage at 20 g/kg dose at 2 h after operation (9). Animals in the EX527 and r-HMGB1 group were also treated with EX527 (10 mg/kg) or r-HMGB1 (100 μg/kg) by intraperitoneal injection, according to the previous article (10,11). ...
Article
Full-text available
Background: Dachengqi decoction (DCQD), one of classic prescription of Chinese herbal medicine has been widely used in clinic to treat severe acute pancreatitis (SAP). The damage of pancreatic microcirculation plays key pathogenesis of SAP. However, little is known about the molecular pharmacological activity of DCQD on pancreatic microcirculation in SAP. Methods: Sodium taurodeoxycholate and cerulein were used to establish model of SAP in vitro and in vivo, respectively. The pancreatic pathological morphology, wet weight ratio, myeloperoxidase (MPO) activity, cell viability and microcirculatory function of the pancreas, as well as serum lipase and amylase expressions were evaluated. The expression levels of SIRT1, acety-HMGB1, TLR-4, HMGB1, IL-23, IL-17A, neutrophil chemokines (KC, LIX, and MIP-2), and inflammation-related factors (IL-6, IL-1β, and TNF-α), the translocation of HMGB1 and the interaction of SIRT-HMGB1 in the pancreas and serum were determined by ELISA real-time PCR, western blotting and immunoprecipitation. Results: In vivo studies showed that DCQD or neutralizing antibody (anti-23p19 or anti-IL-17A) could all significantly decrease lipase, amylase activity, down-regulate the expression of CD68, Myeloperoxidase (MPO), wet/weight, IL-1β, IL-6, TNF-α, and neutrophil chemokines (KC, LIX, MIP-2), alleviate pathological injury and improve pancreatic microcirculatory function in rats with SAP. Furthermore, DCQD remarkably increased SIRT1 expression, promoted SIRT1 and HMGB1 combination, reduced HMGB1 translocation from nuclear to cytoplasm, and alleviated the expression of acetyl-HMGB1, HMGB1, IL-17A, TLR-4, and IL-23 in vitro and in vivo with SAP. However, the intervention with EX527 (SIRT1 inhibitor) or r-HMGB1 (recombinant HMGB1) obliviously reverses the above mentioned influence mentioned above of DCQD in SAP. In vitro, we confirmed that DCQD could decrease HMGB1 acetylation, migration, and release, and improve the decline of cell viability, SIRT1 expression and SIRI-HMGB1 combination induced by cerulean with promoting macrophage to release IL-23 by relying on the HMGB1/TLR-4 way. Conclusions: DCQD treatment improves SAP-induced pancreatic microcirculatory dysfunction by inhibiting neutrophil-mediated inflammation via inactivating HMGB1-TLR-4-IL-23-IL-17A signaling by targeting SIRT1.
... Its active ingredients include rhubarb, mirabilite, Fructus aurantii, and Magnolia o cinalis [7]. DCQD seems to be positively associated with improving microcirculation of pancreas in SAP [8][9]. However, it is a pity the concrete mechanism that sustains the in uence DCQD on microcirculation is not clear up to date. ...
... The nally collected DCQ granules were dissolved in saline to obtain the DCQD (2 g/ml). The concrete speci c compatibility, steps, extraction and use was according to the previous article [9]. ...
... The insulin injection needle was stretched into biliopancreatic duct by means of the nipple, and sodium taurocholate (1mg/kg) got into the biliopancreatic duc by injection. After 2h of injecting sodium taurocholate, the animal in the EX527, DCQD and r-HMGB1 group were treated with DCQD using an oral gavage at a dose of 20 g/kg at 2h after operation [9]. The animals in the EX527 and r-HMGB1 group were also treated with EX527 (10mg/kg) or r-HMGB1 (100μg /kg ) by intraperitoneal injection in according with previous article [10,11]. ...
Preprint
Full-text available
Background Dachengqi decoction (DCQD), one of classic prescription of Chinese herbal medicine has been widely used in clinic to treat severe acute pancreatitis (SAP). The damage of pancreatic microcirculation plays key pathogenesis of SAP. However, little is known about the molecular pharmacological activity of DCQD on pancreatic microcirculation in SAP. Therefore, the purpose of the study attempted to confirm the improvement of DCQD on pancreatic microcirculation is associated with suppressing neutrophil mediated immune-inflammatory response through promoting the inactivation of HMGB1-TLR-4-IL-23-IL-17A axis via targeting the SIRT1 signal pathway in SAP.Material and Methods Sodium taurodeoxycholate and cerulein were used to establish model of SAP in vitro and vivo, respectively. The pancreatic pathological morphology, wet weight ratio, myeloperoxidase (MPO) activity, cell viability and microcirculatory function of the pancreas, as well as serum lipase and amylase expressions were evaluated. The expression levels of SIRT1, acety-HMGB1, TLR-4, HMGB1, IL-23, IL-17A, neutrophil chemokines (KC, LIX, and MIP-2), and inflammation-related factors (IL-6, IL-1β, and TNF-α), the translocation of HMGB1 and the interaction of SIRT-HMGB1 in the pancreas and serum were determined by ELISA real-time PCR, western blotting and immunoprecipitation.ResultsIn-vivo studies showed DCQD or neutralizing antibody (anti-23p19 or anti-IL-17A) could significantly decrease the activity of lipase, amylase, down-regulate the expression of CD68, MPO, wet/weight, IL-1β, IL-6, TNF-α,neutrophil chemokines (KC, LIX, MIP-2 ), alleviate pathological injury, and improve the microcirculatory function of the pancreas in rats with SAP. Moreover, DCQD remarkably augmented SIRT1 expression, promoted SIRT1 and HMGB1 combination, reduced HMGB1 translocation from nuclear to cytoplasm, and alleviated the expression of acetyl-HMGB1, HMGB1, IL-17A, TLR-4 and IL-23 in vitro and vivo with SAP. However, the intervention with EX527 (SIRT1 inhibitor) or r-HMGB1 (recombinant HMGB1) could obliviously reverse the above-mentioned influence of DCQD in SAP. In vitro, we confirmed that DCQD could decrease the acetylation, migration and release of HMGB1, and improve the decline of cell viability, SIRT1, SIRI-HMGB1 combination induced by cerulein with promoting macrophage to release IL-23 through HMGB1/TLR-4. ConclusionDCQD treatment improves SAP-induced pancreatic microcirculatory dysfunction by inhibiting neutrophil-mediated inflammation through the inactivation of HMGB1-TLR-4-IL-23-IL-17A signaling via Targeting SIRT1.Trial registration: No. 365, 2020.
... Recent clinical research has shown that DCQD could help to restore the recovery of intestinal mucosal permeability, relieve intra-abdominal hypertension, decrease the incidence of multiple organ dysfunction syndrome (MODS), and shorten the length of hospitalization in AP patients [10][11][12] . Some animal experiments have demonstrated that DCQD could increase cell viability, promote the transformation of injured acinar cells from necrosis to apoptosis, and protect the pancreas from injury in vivo and in vitro [13,14] . Our previous studies have shown that DCQD could protect multiple organs (pancreas, lungs, kidneys, and intestines) from injury caused by excessive inflammatory responses and confirmed that the anti-inflammatory effects of DCQD on these organs were associated with its tissue distribution [9,15,16] . ...
... In the first part, rats were divided into four groups (n = 6 per group) randomly: One sham-operated group (SOG 1 ) and three model groups (MG 1 , MG 2 , and MG 3 ). After the rats were anesthetized with 2% sodium pentobarbital (intraperitoneal injection, 40 mg/kg), the AP model was induced as described previously [14] . Briefly, 3% sodium taurocholate (1 mL/kg) was retrogradely poured into the biliopancreatic duct; the speed of administration was controlled by a micro-infusion pump at 0.1 mL/min. ...
... A recent study demonstrated that DCQD can further reduce the risk of SIRS via decreasing the secretion of HMGB1 in SAP [47] . DCQD could also induce the pancreas to be more resistant to stress and microcirculation disorders by clearing away excessive reactive oxygen species and regulating the apoptosis/necrosis switch in pancreatic acinar cells [14,48] . Moreover, emodin, one of the most active compounds from the Chinese herb Dahuang, has been used for many years in China to treat acute severe diseases, including AP [49] . ...
Article
Full-text available
Background: Acute pancreatitis (AP) is a pancreatic inflammatory disorder that is commonly complicated by extrapancreatic organ dysfunction. Dachengqi decoction (DCQD) has a potential role in protecting the extrapancreatic organs, but the optimal oral administration time remains unclear. Aim: To screen the appropriate oral administration time of DCQD for the protection of extrapancreatic organs based on the pharmacokinetics and pharmacodynamics of AP rats. Methods: This study consisted of two parts. In the first part, 24 rats were divided into a sham-operated group and three model groups. The four groups were intragastrically administered with DCQD (10 g/kg) at 4 h, 4 h, 12 h, and 24 h postoperatively, respectively. Tail vein blood was taken at nine time points after administration, and then the rats were euthanized and the extrapancreatic organ tissues were immediately collected. Finally, the concentrations of the major DCQD components in all samples were detected. In the second part, 84 rats were divided into a sham-operated group, as well as 4 h, 12 h, and 24 h treatment groups and corresponding control groups (4 h, 12 h, and 24 h control groups). Rats in the treatment groups were intragastrically administered with DCQD (10 g/kg) at 4 h, 12 h, and 24 h postoperatively, respectively, and rats in the control groups were administered with normal saline at the same time points. Then, six rats from each group were euthanized at 4 h and 24 h after administration. Serum amylase and inflammatory mediators, and pathological scores of extrapancreatic organ tissues were evaluated. Results: For part one, the pharmacokinetic parameters (C max, T max, T 1/2, and AUC 0 → t) of the major DCQD components and the tissue distribution of most DCQD components were better when administering DCQD at the later (12 h and 24 h) time points. For part two, delayed administration of DCQD resulted in lower IL-6 and amylase levels and relatively higher IL-10 levels, and pathological injury of extrapancreatic organ tissues was slightly less at 4 h after administration, while the results were similar between the treatment and corresponding control groups at 24 h after administration. Conclusion: Delayed administration of DCQD might reduce pancreatic exocrine secretions and ameliorate pathological injury in the extrapancreatic organs of AP rats, demonstrating that the late time is the optimal dosing time.
... Nowadays ). Over the years, many studies have shown that DCQD is a secure, effective drug on AP [5,6]. ...
... e fingerprint chromatogram of DCQD has been identified by using a HPLC method (additional file, Figure 2), in which the major peaks were identified by comparing both the retention times of both DCQD and the reference standards. Notably, 9 compounds in DCQD, viz., [1] naringin, [2] hesperidin, [3] aloe-emodin, [4] rhein B, [5] honokiol, [6] magnolol, [7] emodin, [8] chrysophanol, and [9] physcion, were properly identified. e results of fingerprint chromatogram of several batches of DCQD showed good repeatability. ...
Article
Full-text available
Background. Acute pancreatitis (AP) is a common acute abdomen inflammation, characterized by the dysregulation of digestive enzyme production and secretion. Many studies have shown that Da Cheng Qi Decoction (DCQD) is a secure, effective prescription on AP. In this study, cerulein-stimulated AR42J cells damage model was established to further explore the feasibility and underlying mechanism of DCQD as a potential inhibitor of JAK2/STAT3 pathway for the treatment of AP. Methods. Cell viability of DCQD was measured using a cell counting Kit-8 assay. Pancreatic biochemical markers such as amylase, lipase, and C-reactive protein production were measured by assay kits, respectively. Cytokines (TNF-α, IL-6, IL-10, and IL-1β) were assayed by ELISA. Protein location and protein expression were detected by immunofluorescence staining and Western blotting, respectively. Gene expression was assessed by real-time PCR. For mechanistic analysis of the effect of DCQD on JAK2/STAT3 signaling pathway, selective JAK2 inhibitor (Fedratinib) and STAT3 inhibitor (Stattic) as well as STAT3 activator (Garcinone D) were used. Results. DCQD protected cells by regulating cerulein-induced inflammation and reducing the secretion of pancreatic biochemical markers. Moreover, DCQD could not only inhibit the nuclear translocation of p-STAT3, but also decrease the mRNA expression of JAK2 and STAT3 as well as the ratio of p-JAK2/JAK2 and p-STAT3/STAT3 in protein level. Additionally, DCQD could regulate the mRNA and protein expression of JAK2/STAT3 downstream effectors, Bax and Bcl-XL. The activated effect of cerulein on JAK2/STAT3 pathway was also reversed by JAK2 inhibitor Fedratinib or STAT3 inhibitor Stattic. And the overexpression of JAK2/STAT3 pathway, via STAT3 activator Garcinone D, did exert damage on cells, which bore a resemblance to cerulein. Conclusion. The activation of JAK2/STAT3 pathway may play a key role in the pathogenesis of cerulein-stimulated AR42J pancreatic acinar cell injury. DCQD could improve inflammatory cytokines and cell injury, which might be mediated by suppressing the activation of JAK2/STAT3 signaling pathway. 1. Background Acute pancreatitis (AP) is a common acute abdomen inflammation, of which severe complication involves systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndromes (MODS) [1, 2]. The incidence and prevalence of AP have been increasing worldwide and have a great influence on life quality and work ability. Growing evidences have shown that several factors, including cholelithiasis, alcoholism, and smoking, increase the incidence and mortality burden [3]. Currently, due to the lack of available medicines, the mainstay of treatment for AP is based on surgery [4]. However, poor surgical prognosis and high recurrence rate have made the operation result unsatisfactory. Nowadays, Traditional Chinese Medicine (TCM) has become one of the most popular complementary and alternative therapies in the world. Da Cheng Qi Decoction (DCQD), a famous formula recorded in Shang Han Lun, consists of Rheum officinale Baill. (Da Huang), Magnolia officinalis Rehder & E.H.Wilson (Hou Pu), Fructus Aurantii Immaturus (Zhi Shi), and Natrii Sulfas (Mang Xiao). Over the years, many studies have shown that DCQD is a secure, effective drug on AP [5, 6]. Presently, more and more clinical studies have proven that the levels of a few pro- and anti-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and interleukin (IL)-10, are elevated early in patients with AP [7]. Determining the severity of inflammatory reaction at admission does contribute to predicting clinical outcome in AP. On the other hand, as one of the principal signaling pathways for cytokines and growth factors, Janus kinase 2 signal transducers and transcription 3 (JAK2/STAT3) signaling pathway is essential for the innate immunity and suppression of inflammation [8]. In addition, many researchers suggested that JAK2/STAT3 signaling pathway acts as an important role in the pathogenesis and development of AP [9, 10]. Inflammatory cytokines can participate in the pathogenesis of AP by activating JAK2/STAT3 pathway [11]. At the same time, many drugs can treat AP through JAK2/STAT3 pathway [12, 13]. Moreover, based on the enrichment results of KEGG (Kyoto Encyclopedia of Genes and Genomes) in network pharmacology and proteome research in our previous research, JAK2/STAT3 signal pathway may be the key of DCQD in interfering with AP. Although a previous study sporadically showed that DCQD could regulate inflammatory cytokines and intestine injury in rats with severe acute pancreatitis via JAK2/STAT3 signaling pathway [14], the potential mechanism of DCQD participating in AP through JAK2/STAT3 is not clear. A simple and feasible in vitro model of AP should be considered. In this study, cerulein-induced AR42J cells damage model was established to further explore the feasibility and underlying mechanism of DCQD as a potential JAK2/STAT3 inhibitor for the treatment of AP (additional file, Figure 1). (a)
... Da-cheng-qi decoction could induce apoptosis in acinar cells by increasing the amount of nitric oxide (NO) and activity of inducible NO synthetase, which plays a pivotal role in regulating apoptosis and necrosis, and preventing further deterioration of the pancreas. 21,22 In addition, DCQD could also induce acinar cell apoptosis by regulating serum IL-6 and sIL-2R levels, thus reducing the severity of SAP. 23 ...
Article
Acute pancreatitis (AP) is a common clinical gastrointestinal disorder with a high mortality rate for severe AP and lacks effective clinical treatment, which leads to considerable comorbidity and financial burden. Traditional Chinese medicine (TCM) has had the unique advantage of treating AP for a long time in China. Clinically, TCM formulas such as Da-cheng-qi decoction, Chai-qin-cheng-qi decoction, Qing-yi decoction, Da-chai-hu decoction, and Da-huang-fu-zi decoction are widely adminis-trated to AP patients. All of these TCM formulas can improve gastrointes-tinal function, regulate the inflammatory response, and enhance immunity, thus preventing complications, reducing the mortality rate and financial burden. This review will summarize the pharmacological activities and mechanisms of TCM formulas in alleviating AP. Abbreviations: AP-acute pancreatitis, SAP-severe acute pancreatitis, TCM-traditional Chinese medicine, DCQD-Da-cheng-qi decoction, QYD-Qing-yi decoction, CQCQD-Chai-qin-cheng-qi decoction, DCHD-Da-chai-hu decoction, DHFZD-Da-huang-fu-zi decoction, CRP-C-reactive protein, HMGB1-high-mobility group box 1 protein, NF-κB-nuclear factor-kappa B, SIRS-system inflammatory reaction syndrome, MODS-multiple organ dysfunction syndrome, IL-interleukin, AMY-amylase, LPS-lipase, TNF-α-tumor necrosis factor α, CD-the cluster of differentiation, Ig-immunoglobulin, NO-nitric oxide, VIP-vasoactive intestinal peptide, GAS-gastrin, MTL-motilin, ET-endotoxin, MCP-1-monocyte chemoattractant protein-1, TLR4-toll-like receptor 4, CCKR1-cholecystokinin receptor 1, AQP-aquaporin, PT-prothrombin time, APTT-activated partial thromboplastin time, FIB-fibrinogen, PLT-platelets (Pancreas 2021;50: 1348-1356) A cute pancreatitis (AP), as one of the common causes of acute abdomen, has an annual incidence that ranges from 13 to 45 per 100,000 persons, 1 whereas severe AP (SAP) has a high mortality rate of 30% to 50%. 2,3 The treatment of AP includes symptomatic support, drug therapy, aggressive intravenous fluid resuscitation , and enteral nutrition; however, effective clinical treatment is still lacking. 4 Traditional Chinese medicine (TCM) has the distinctive preponderance in treating AP for a long time in China. In 2015, the "Chinese Consensus on the Multidisciplinary Treatment (MDT) of Acute Pancreatitis" pointed out that the use of TCM can effectively relieve the inflammation of the pancreas 5 and recommended the administration of TCM formulas such as Da-cheng-qi decoction (DCQD) and Qing-yi decoction (QYD) in the acute phase of AP. At present, in addition to DCQD and QYD, the universally used TCM formulas for AP include Chai-qin-cheng-qi decoction (CQCQD), Da-chai-hu decoction (DCHD), and Da-huang-fu-zi decoction (DHFZD). To obtain a general understanding and explore the potential drugs, we summarized the TCM formulas and their active monomers that are extensively used in the treatment of AP and discussed their pharmacological activities and mechanisms in this review. TCM FORMULAS FOR AP Traditional Chinese medicine formulas have been reported to have clinical efficacy in AP, evidenced by results from abundant animal experiments and clinical studies summarized in Tables 1 and 2. Da-Cheng-Qi Decoction Da-cheng-qi decoction was originally documented in Shang Han Lun (Treatise on Febrile Diseases), a classic TCM masterpiece. It consists of Radix Et Rhizoma Rhei (Dahuang), Cortex Magnoliae Officinalis (Houpu), Fructus Aurantii Immaturus (Zhishi), and Natrii Sulphas (Mangxiao), 6 which is used for AP, intestinal obstruction, biliary tract infection, and others. 7 Mechanism of DCQD on AP Improves Gastrointestinal Function A multicenter randomized controlled trial of DCQD in SAP patients found that DCQD could decrease inflammatory mediators , such as C-reactive protein (CRP) and white blood cells, not only relieving abdominal pain and distension but also reducing hospitalization costs and shortening the length of hospital stay. 8 It could also promote the recovery of intestinal mucosal permeability and relieve intra-abdominal hypertension in SAP patients. 9,10 In the field of basic research, DCQD was conductive to repair and maintain the integrity of the enteric nerve network damaged by intestinal substances. 11 Da-cheng-qi decoction might promote intestinal function by reducing the expression of the 5-hydroxytryptamine 7
... However, its mechanism and pathway of action are still unclear. Studies have shown that DCQD can promote apoptosis and reduce necrosis of pancreatic acinar cells in both in vivo and in vitro AP models (Chang et al.,2011;Ma et al.,2020;Wang et al.,2012). However, the mechanism of regulation of autophagy of pancreatic alveolar cells in AP by DCQD is unclear. ...
Preprint
Full-text available
Objective: Acute pancreatitis (AP) is a common acute abdominal disease characterized by pancreatic acinar cell death and inflammation. Excessive autophagy of acinar cells will aggravate AP, further develop into SAP, and even endanger life. Dachengqi Decoction (DCQD) is a commonly used drug in clinic for acute pancreatitis. Beclin1 is a vital autophagy-related molecule in disease. We investigated DCQD treat acute pancreatitis by intervening Beclin1 to regulate the autophagy of acinar cells. Methods: Wistar rats were injected intraperitoneally with 20% L-arginine to reproduce AP rat model. AP rat were treated with DCQD and 3-Methyladenine (3-MA) and compared to AP rats pre-treated with 20% L-arginine. we examined the levels of serum TNF-α, Beclin1 and Reactive Oxygen Species (ROS) by ELISA; stained the pancreas tissues of rats with Hematoxylin-eosin staining (HE); observed the autophagy formation in pancreas tissues by transmission electron microscopy; and detected the expression of Beclin1 and light chain 3-Ⅱ(LC3-II) protein level in pancreas tissues by Western blot and immunohistochemistry. Result: The levels of serum Amylase, Beclin1, ROS, TNF-α and pathological scores of pancreas were significantly elevated by injected intraperitoneally with 20% L-arginine. The results of electron microscopy showed that the autophagy of pancreatic tissue increased significantly in AP rats, but decreased in rats treated with DCQD or 3-MA. DCQD and 3-MA could significantly reduce the levels of serum Amylase, Beclin1, ROS and TNF-α in rats. Western blot and immunohistochemical results showed that DCQD and 3-MA significantly reduced Beclin1 and LC3-II proteins. Conclusion: Our studies showed that Beclin1 is closely related to acute pancreatitis, and DCQD could inhabited Beclin1 and excessive autophagy.
... Acute pancreatitis (AP) is an inflammatory disorder that has been found to be associated with systemic inflammatory response syndrome and multiple organ dysfunction syndrome (1,2). In individuals with AP, apoptotic and necrotic cell death are two major pathways contributing to the severity and mortality of AP (3)(4)(5). Apoptotic cell death is considered to protect individuals with pancreatitis from a mild inflammatory response, while necrosis leads to systemic damage in the pathology of severe AP, due to the activation of digestive enzymes and other inflammatory mediators (4)(5)(6)(7). Hence, approaches targeting necrosis may have great therapeutic potential for the treatment of severe AP. ...
Article
Full-text available
Acute pancreatitis (AP) is an inflammatory disorder that has been associated with systemic inflammatory response syndrome. Ginsenoside Rg3 is a major active component of Panax ginseng, which has been demonstrated to exert potent protective effects on hyperglycemia and diabetes. However, it remains to be determined whether Rg3 ameliorates AP. Thus, an in vitro AP cell model was established in the present study by exposing AR42J cells to cerulein (Cn). AR42J cell viability was increased in the Rg3‑treated group as compared with the Cn‑exposed group. Simultaneously, the number of dead AR42J cells was decreased in the Rg3‑treated group compared with the group treated with Cn only. Furthermore, following treatment with Rg3, the production of malondialdehyde (MDA) and ferrous ion (Fe2+) in the AR42J cells was reduced, accompanied by increased glutathione (GSH) levels. Western blot analysis revealed that the decrease in glutathione peroxidase 4 (GPX4) and cystine/glutamate transporter (xCT) levels induced by Cn were reversed by Rg3 treatment in the AR42J cells. Mice treated with Cn exhibited increased serum amylase levels, as well as increased levels of TNFα, IL‑6, IL‑1β, pancreatic MDA, reactive oxygen species (ROS) and Fe2+ production. Following Rg3 treatment, ROS accumulation and cell death were decreased in the pancreatic tissues compared with the AP group. Furthermore, in the pancreatic tissues of the AP model, the expression of nuclear factor‑erythroid factor 2‑related factor 2 (NRF2)/heme oxygenase 1 (HO‑1)/xCT/GPX4 was suppressed. In comparison, the NRF2/HO‑1/xCT/GPX4 pathway was activated in pancreatic tissues following Rg3 administration. Taken together, the present study, to the best of our knowledge, is the first to reveal a protective role for Rg3 in mice with AP by suppressing oxidative stress‑related ferroptosis and the activation of the NRF2/HO‑1 pathway.
... Acute pancreatitis (AP) is an inflammatory disease that activates a cascade-like response of inflammatory factors, thereby inducing Systemic inflammatory response syndrome (SIRS). 1,2 Evidence suggests that severe acute pancreatitis (SAP), characterized by multiple organ failure, has a high mortality rate compared to mild acute pancreatitis (MAP). 3,4 Therefore, increased attention has been subjected to SAP research, with molecular studies focusing on the activation of cytokine, macrophagemediated inflammatory response, and neutrophil infiltration. ...
Article
Full-text available
Objective Systemic immune-inflammation index (SII) is a new systemic inflammatory prognostic indicator associated with outcomes in patients with different tumors. Studies have shown an association between SII and many chronic/acute inflammatory diseases. This study aimed at exploring whether SII can be used as an effective parameter for predicting the severity of acute pancreatitis (AP). Methods A total of 101 acute pancreatitis patients were enrolled in this study (mild acute pancreatitis (MAP): n = 73 and severe acute pancreatitis (SAP): n = 28). Patient demographics and SII were analyzed using the chi-square test, Student’s t-test, and Mann–Whitney U-test. A receiver operating characteristic curve was generated to test the potential of using neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and SII to predict AP’s severity. Logistic regression analysis was performed to determine major risk factors. Results Patients with SII value ≥2207.53 had a higher probability of having SAP (sensitivity = 92.9%, specificity = 87.7%, and AUC = 0.920), and SII was a significantly better predictive value than PLR and NLR. Logistic regression analysis results showed SII could differentiate MAP from SAP as a major risk factor. Conclusion This study has shown that SII is a potential indicator for predicting the severity of acute pancreatitis. The findings suggested that SII is more sensitive and specific than NLR and PLR in predicting the severity of acute pancreatitis.
... Natrii sulfas (Mang XIAOXiao). Over the years, many studies have shown that DCQD is a secure, effective drug on AP (6,7). ...
Preprint
Full-text available
Background: Acute pancreatitis (AP) is a common acute abdomen, characterized by the dysregulation of digestive enzyme production and secretion. Many studies have shown that Da Cheng Qi Decoction (DCQD) is a secure, effective prescription on AP. In this study, cerulein-stimulated AR42J cells damage model was established to further explore the feasibility and underlying mechanism of DCQD as a potential JAK2/STAT3 pathway inhibitor for the treatment of AP. Methods: Cell viability of DCQD was measured using a Cell Counting Kit-8 assay. Pancreatic biochemical markers such as amylase, lipase and C-reactive protein production were measured by assay kits respectively. Cytokines (TNF-α, IL-6, IL-10 and IL-1β) were assayed by ELISA. Protein location was detected by immunofluorescence staining. Proteins expression was quantified by Western blotting, and gene expression was assessed by real‑time PCR. For mechanistic analysis of the effect of DCQD on JAK2/STAT3 signaling pathway, selective JAK2 inhibitor (Fedratinib) and STAT3 inhibitor (Stattic) as well as STAT3 activator (Garcinone D) were used. Results: DCQD protected cells by regulating cerulein-induced inflammation and reducing the secretion of pancreatic biochemical markers. The mechanisms mediating these effects may be related to the suppression of the JAK2/STAT3 pathway. Additionally, DCQD significantly attenuated cell injury and regulated the expression of downstream targets Bax and Bcl-XL. Moreover, treatment with JAK2 inhibitor Fedratinib or STAT3 inhibitor Stattic reversed the activated effect of cerulein on JAK2/STAT3 pathway. And the activation of JAK2/STAT3 pathway, via STAT3 activator Garcinone D, did exert damage on cells, which bore a resemblance to cerulein. Conclusion: The activation of JAK2/STAT3 pathway may play a key role in the pathogenesis of cerulein-stimulated AR42J pancreatic acinar cell injury. DCQD could improve inflammatory cytokines and cell injury, which might be mediated by suppressing the activation of JAK2/STAT3 signaling pathway.
Article
Acute pancreatitis (AP) is a common clinical gastrointestinal disorder with a high mortality rate for severe AP and lacks effective clinical treatment, which leads to considerable comorbidity and financial burden. Traditional Chinese medicine (TCM) has had the unique advantage of treating AP for a long time in China. Clinically, TCM formulas such as Da-cheng-qi decoction, Chai-qin-cheng-qi decoction, Qing-yi decoction, Da-chai-hu decoction, and Da-huang-fu-zi decoction are widely administrated to AP patients. All of these TCM formulas can improve gastrointestinal function, regulate the inflammatory response, and enhance immunity, thus preventing complications, reducing the mortality rate and financial burden. This review will summarize the pharmacological activities and mechanisms of TCM formulas in alleviating AP.
Article
Full-text available
Emodin is one of major compounds in rhubarb (Rheum palmatum L.), a plant used as herbal medicine in Chinese population. Although many reports have shown that emodin exhibits anticancer activity in many tumor cell types, there is no available information addressing emodin-affected apoptotic responses in the murine leukemia cell line (WEHI-3) and modulation of the immune response in leukemia mice. We investigated that emodin induced cytotoxic effects in vitro and affected WEHI-3 cells in vivo. This study showed that emodin decreased viability and induced DNA fragmentation in WEHI-3 cells. Cells after exposure to emodin for 24 h have shown chromatin condensation and DNA damage. Emodin stimulated the productions of ROS and Ca(2+) and reduced the level of ΔΨ(m) by flow cytometry. Our results from Western blotting suggest that emodin triggered apoptosis of WEHI-3 cells through the endoplasmic reticulum (ER) stress, caspase cascade-dependent and -independent mitochondrial pathways. In in vivo study, emodin enhanced the levels of B cells and monocytes, and it also reduced the weights of liver and spleen compared with leukemia mice. Emodin promoted phagocytic activity by monocytes and macrophages in comparison to the leukemia mice group. In conclusions, emodin induced apoptotic death in murine leukemia WEHI-3 cells and enhanced phagocytosis in the leukemia animal model.
Article
Full-text available
Silibinin mostly has been used as hepatoprotectants, but it has other interesting activities, e.g. anti-cancer, cardial protective and brain-protective activities. A previous study demonstrated that silibinin protected amyloid β (Aβ)-induced mouse cognitive disorder by behavioural pharmacological observation. This study assessed the effect of silibinin on sodium nitroprusside (SNP)-treated rat pheochromocytoma PC12 cells. Subsequent morphologic observation, flow cytometric analysis and Western blot analysis indicated that treatment with SNP significantly induced apoptosis in PC12 cells. However, silibinin eliminated the apoptotic effect by reactive oxygen species (ROS) generation, especially hydroxyl free radical. Silibinin-induced autophagy through ROS generation when exerting a protective effect and silibinin-induced autophagy also enhanced the ROS generation since 3-methyladenine (3-MA), a specific autophagy inhibitor, decreased the ROS generation and rapamycin, an autophagy inducer, enhanced the ROS generation. Therefore, there exists a positive feedback loop between autophagy and ROS generation. Autophagy prevented SNP-induced apoptosis, since the addition of 3-MA significantly eliminated the protective effect of silibinin. This protective effect was attributed to the generation of ROS and its two downstream Ras/PI3K/NF-κB and Ras/Raf/MEK/ERK pathways. Both prevented PC12 cells from apoptosis. The PI3K/NF-κB pathway induced autophagy to protect PC12 cells, but the Raf/MEK/ERK pathway directly protected PC12 cells bypassing the autophagic effect.
Article
Full-text available
Background and aims Reg4 is a recently discovered member of the regenerating gene family with distinctive expression profiles in primary cancers. To date, the physiological function of Reg4 is poorly understood. Previously, the authors found that Reg4 was markedly upregulated during acute pancreatitis (AP). The aim of this study was to investigate the role of Reg4 in experimental pancreatitis. Methods AP was induced in C57BL/6 mice by administration of either l-arginine or caerulein, and Reg4 expression was assessed by immunofluorescence, reverse transcriptase (RT)-PCR and western blot analyses. Recombinant human Reg4 protein (rReg4), heat-inactivated Reg4, neutralising antibody and vehicle were also administered to mice by subcutaneous injection. The severity of AP was determined by measuring amylase and lipase activities in the serum and histological grading. The effect of rReg4 on cell death was examined and epidermal growth factor receptor (EGFR), p-EGFR, Akt, p-Akt, Bcl-2 and Bcl-xL expression were assessed by western blot analysis of isolated murine acinar cells treated with l-arginine. Results Reg4 mRNA and protein were markedly upregulated during arginine-induced pancreatitis. Reg4 was widely expressed in residual acinar cells around the islets and regenerating metaplastic epithelium. rReg4 could protect against arginine-induced necrosis of acinar cells both in vivo and in vitro. This protective effect was also confirmed in the caerulein-induced murine model of AP. It was shown that arginine induced expression of Bcl-2 and Bcl-xL, while rReg4 upregulated Bcl-2 and Bcl-xL expression by activating the EGFR/Akt pathway. The upregulation of Bcl-xL correlated inversely with cell necrosis in isolated pancreatic acinar cells. Conclusions The data suggest that Reg4 may protect against acinar cell necrosis in experimental pancreatitis by enhancing the expression of Bcl-2 and Bcl-xL via activation of the EGFR/Akt signalling pathway.
Article
Full-text available
The Grim RIPper Cells can undergo regulated cell death through distinct processes known as apoptosis and necrosis. Regulation of apoptosis is better understood than that of necrosis. In a screen for gene products that participate in control of necrosis in cells treated with TNF (tumor necrosis factor), D.-W. Zhang et al. (p. 332 ; published online 4 June) identified a protein kinase, RIP3. In cells treated with TNF and a caspase inhibitor that inhibits apoptosis, seven metabolic enzymes interacted with RIP3, some of which are associated with mitochondria. Generation of reactive oxygen species was necessary for TNF-induced necrosis, and depletion of RIP3 reduced the generation of reactive oxygen species. Thus, RIP3 may participate in the mechanisms that link energy metabolism with mechanisms of cell death.
Article
An enhanced formation of nitric oxide (NO), due to the induction of inducible nitric oxide synthase (NOS), has been implicated in the pathogenesis of shock and inflammation, but its role in acute pancreatitis still remains controversial. To clarify the role of NO in acute pancreatitis, the present experiment investigated the expression of NOS and the effect of NOS inhibition on cerulein-induced pancreatitis in rats. Group I received intraperitoneal (ip) injection of normal saline. Group 11 received two ip injections of cerulein (20 mug/kg). Group III received injections of N-G-nitro-L-arginine methyl ester (L-NAME) (30 mg/kg) with cerulein. Group IV received L-arginine (250 mg/kg) with cerulein and L-NAME. The expression of NOS in the pancreas was examined by western blot analysis. The plasma concentration of NO metabolites was measured. The severity of pancreatitis was assessed by measuring serum amylase, pancreas water content and histopathological examination. Compared with controls, the cerulein group displayed significantly increased expression of NOS and raised plasma NO metabolites. Treatment with L-NAME significantly decreased hyperamylasemia, plasma NO level, and the extent of pancreatic injury. Treatment with L-arginine reversed the effects of L-NAME. Those findings suggest that an enhanced formation of NO by NOS plays an important role in the development of acute pancreatitis, and inhibition of NO production has the beneficial effects in reducing pancreas injury.
Article
To investigate the effect of dexamethasone (Dx) combined with modified Dachengqi Decoction (DCQD), a Chinese herbal decoction for purgation, on patients with severe acute on patients with severe acute, a Chinese herbal decoction for purgation, on patients with severe acute pancreatitis (SAP) accompanied with systematic inflammatory response syndrome (SIRS). A total of 81 patients diagnosed as SAP were randomly assigned to a control group or treatment group according to a random number table generated from an SPSS software. The patients in the control group (38 cases) received standard treatment and Chinese herbal decoction for purgation; those in the treatment group (43 cases) received additional 1 mg/(kg·d) dexamethasone (Dx) treatment for three days based on the above treatment. The mortality rate, acute respiratory distress syndrome (ARDS), renal failure, hemorrhage, sepsis, pancreatic pseudocyst, pancreatic abscess, operability, and days of hospitalization were compared between the two groups. Three patients in the control group and eight patients in the treatment group dropped out from the study with a drop-out rate of 7.8% and 18.6%, respectively, and no statistics difference was shown between the two groups (P>0.05). Dx treatment significantly reduced ARDS rate and shortened the length of hospitalization compared to those in the control group (7/35, 20.0% versus 15/35, 42.9%, P=0.0394; 32.5±13.2 days versus 40.2±17.5 days, P=0.0344). Other parameters including the mortality rate were not significant different between the two groups. Dx combined with DCQD could decrease the risk of developing ARDS in SAP patients with SIRS and shorten their length of hospitalization.
Article
Oxidative stress is implicated in the pathogenesis of pancreatitis, but clinical trials of antioxidants have produced conflicting results. We examined the role of intracellular reactive oxygen species (ROS) in pancreatic acinar cell injury. Freshly isolated murine and human pancreatic acinar cells were studied using confocal microscopy to measure changes in intracellular and mitochondrial ROS concentrations ([ROS]I and [ROS]M), cytosolic and mitochondrial calcium concentrations ([Ca2+]C and [Ca2+]M), reduced nicotinamide adenine dinucleotide phosphate levels, and death pathways in response to taurolithocholate acid sulfate (TLC-S) or the oxidant menadione. Ca2+-activated Cl- currents were measured using whole-cell patch clamp, with or without adenosine triphosphate (ATP). TLC-S induced prolonged increases in [Ca2+]C and [Ca2+]M, which led to dose-dependent increases in [ROS]I and [ROS]M, impaired production of ATP, apoptosis, and necrosis. Inhibition of the antioxidant reduced nicotinamide adenine dinucleotide phosphate quinine oxidoreductase by 2,4-dimethoxy-2-methylnaphthalene potentiated the increases in [ROS]I and apoptosis but reduced necrosis, whereas the antioxidant N-acetyl-L-cysteine reduced [ROS]I and apoptosis but increased necrosis. Inhibition of mitochondrial ROS production prevented apoptosis but did not alter necrosis; autophagy had no detectable role. Patched ATP prevented sustained increases in [Ca2+]C and necrosis. Increases in [ROS]M and [ROS]I during bile acid injury of pancreatic acinar cells promote apoptosis but not necrosis. These results indicate that alternative strategies to antioxidants are required for oxidative stress in acute pancreatitis.
Article
To investigate the effect of severe acute pancreatitis (SAP) on pharmacokinetics of Da-Cheng-Qi Decoction (DCQD) components in rats. Rats were divided into SAP group and sham-operation group as a control group (n = 6). Rhein, chrysophanol, rheochrysidin, magnolol, hesperidin and naringin in DCQD were quantified in rat serum by high performance liquid chromatography tandem mass spectrometry for studying their pharmacokinetics. Early absorption of each DCQD component was tended to degrade in SAP group after treatment with DCQD by gavage. The C(max) (chrysophanol, P = 0.0059; rheochrysidin, P = 0.0288; magnolol, P = 0.0487; hesperidin, P = 0.0277; naringin, P = 0.0023) and AUC (rhein, P = 0.0186; chrysophanol, P = 0.0013; magnolol, P = 0.001; hesperidin, P = 0.0081; naringin, P = 0.0272) of DCQD component were obviously lower in SAP group than in control group. The T(1/2alpha) of chrysophanol and rheochrysidin (P = 0.0467 and 0.0005, respectively) and T(max) of chrysophanol and rheochrysidin (P = 0.0101 and 0.0037, respectively) lasted longer in SAP group than in control group. SAP can significantly impact the absorption of DCQD components in rats and their pharmacokinetic parameters.
Article
Acute pancreatitis is a common clinical condition. Excessive systemic inflammatory response syndrome (SIRS) in acute pancreatitis leads to distant organ damage and multiple organ dysfunction syndrome (MODS), which is the primary cause of morbidity and mortality in this condition. Development of in vivo experimental models of acute pancreatitis and associated systemic organ damage has enabled us to study the role played by inflammatory mediators in the pathogenesis of acute pancreatitis and associated systemic organ damage. Using these models, recent studies by us and other investigators have established the critical role played by inflammatory mediators such as TNF-a, IL-1b, IL-6, PAF, IL-10, CD40L, C5a, ICAM-1, chemokines, substance P and hydrogen sulfide in acute pancreatitis and the resultant MODS. This chapter intends to present an overview of different experimental animal models of acute pancreatitis and associated MODS and the role of inflammatory mediators in the pathogenesis of this condition.